Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 株洲千金药业股份有限公司是一家主要研制、生产、销售中成药的公司,是全国中成药工业重点企业50强.产品有妇科千金片、舒筋风湿酒、补血益母颗粒等,主要产品妇科千金片是国家基本药物、国家中药保护品种和《国家基本医疗保险药品目录》中的甲类药品,该产品畅销全国绝大部分省市.其中片剂、胶囊剂、颗粒剂等生产线获GMP认证。
Main Business 主要从事中成药、化学药和女性卫生用品的研制、生产和销售以及药品的批发和零售业务
Legal Representative 蹇顺
Top Executives
董事长：蹇顺
副董事长：曹道忠
董事：陈军,曹道忠,曾艳,周述勇,蹇顺,谢爱维
独立董事：狄文,马理,周季平
Top 5 Shareholder
Shareholder name Nature Holding Date
株洲市国有资产投资控股集团有限公司流通A股28.16%30/09/2024
招商银行股份有限公司－上证红利交易型开放式指数证券投资基金流通A股3.59%30/09/2024
中国平安人寿保险股份有限公司－分红－个险分红流通A股2.04%30/09/2024
全国社保基金四一三组合流通A股1.82%30/09/2024
湖南省烟草公司株洲市公司流通A股1.63%30/09/2024
Company Secretary 朱溧
Solicitors 湖南启元律师事务所
Auditors 天职国际会计师事务所（特殊普通合伙）
Tel No 0731-22496088
Fax No 0731-22496088
Website www.qjyy.com
Email qianjin@qjyy.com
Company Address
Register: 湖南省株洲市天元区株洲大道801号
Office: 湖南省株洲市天元区株洲大道801号
Listing Date 12/03/2004
Shares Capital
Shares Capital: 423,997,117
Total A Share: 423,997,117
Listed A Share: 418,507,117
Non-tradable A Share: 5,490,000
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.758
DPS(RMB)* ¥ 0.350
NBV Per Share(RMB)* ¥ 5.571
Market Capitalization(RMB) 4.587B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.